Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-02-18 @ 4:10 PM
Study NCT ID:
NCT01274403
Status:
COMPLETED
Last Update Posted:
2011-01-11
First Post:
2010-12-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma
Sponsor:
Gruppo Italiano Studio Linfomi
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MM03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gruppo Italiano Studio Linfoma
Old Organization:
GISL